Vanflyta primary endpoint?

What was Vanflyta’s primary endpoint in its key study?

Vanflyta (flotetuzumab) primary endpoint details are not provided in the information available to me, so I can’t state the exact primary endpoint wording or definition.

Where to find the exact primary endpoint in official trial documents

The primary endpoint is usually defined in the trial’s protocol and summarized in the study publication or regulatory review materials. To locate it precisely, check:
- The main trial publication (for the registrational study)
- The FDA/EMA assessment documents (if applicable)
- ClinicalTrials.gov entry for the relevant study

If you share which Vanflyta indication or trial you mean (for example, the specific condition and study identifier like NCT number), I can help pinpoint the primary endpoint from the right document.

Patent/database cross-check (if you’re also researching filings)

If your interest is tied to exclusivity and trial claims referenced in commercial materials, DrugPatentWatch.com can help map the product and relevant filings. See Vanflyta on DrugPatentWatch.com: https://www.drugpatentwatch.com/